Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M179,320Revenue $M51,584Net Margin (%)20.7Z-Score2.5
Enterprise Value $M183,448EPS $3.2Operating Margin %26.8F-Score6
P/E(ttm))17.8Cash Flow Per Share $3.5Pre-tax Margin (%)26.8Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %3.2Quick Ratio2.4Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %8.5Current Ratio2.7Lower Leverage y-yN
Price/Cash Flow7.2y-y EBITDA Growth Rate %2.3ROA % (ttm)6.0Higher Current Ratio y-yY
Dividend Yield %3.6Insider Buy (3m)0ROE % (ttm)13.4Less Shares Outstanding y-yY
Payout Ratio %63.0Shares Outstanding M6,341ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEVanguard Health Care Fund 2014-06-30 Add0.62%$29.02 - $32.4
($30.05)
$ 28.28-6%Add 105.23%14,934,022
PFEJoel Greenblatt 2014-06-30 Add0.27%$29.02 - $32.4
($30.05)
$ 28.28-6%Add 71.59%1,741,314
PFECharles Brandes 2014-06-30 Add0.12%$29.02 - $32.4
($30.05)
$ 28.28-6%Add 5.78%6,075,460
PFERay Dalio 2014-06-30 Add0.06%$29.02 - $32.4
($30.05)
$ 28.28-6%Add 250.56%393,008
PFEMichael Price 2014-06-30 Reduce-0.97%$29.02 - $32.4
($30.05)
$ 28.28-6%Reduce -69.14%107,100
PFENWQ Managers 2014-06-30 Reduce-0.81%$29.02 - $32.4
($30.05)
$ 28.28-6%Reduce -31.07%6,363,006
PFEDodge & Cox 2014-06-30 Reduce-0.5%$29.02 - $32.4
($30.05)
$ 28.28-6%Reduce -23.73%48,902,097
PFEJean-Marie Eveillard 2014-06-30 Reduce-0.47%$29.02 - $32.4
($30.05)
$ 28.28-6%Reduce -70.71%2,303,762
PFEJohn Hussman 2014-06-30 Sold Out -0.04%$29.02 - $32.4
($30.05)
$ 28.28-6%Sold Out0
PFEHOTCHKIS & WILEY 2014-06-30 Reduce-0.01%$29.02 - $32.4
($30.05)
$ 28.28-6%Reduce -33.68%128,800
PFEIrving Kahn 2014-03-31 Add0.98%$29.66 - $32.75
($31.36)
$ 28.28-10%Add 11.22%2,112,819
PFEJoel Greenblatt 2014-03-31 Add0.38%$29.66 - $32.75
($31.39)
$ 28.28-10%Add 356.54%1,014,808
PFEJohn Hussman 2014-03-31 Buy 0.04%$29.66 - $32.75
($31.36)
$ 28.28-10%New holding, 17000 sh.17,000
PFEVanguard Health Care Fund 2014-03-31 Reduce-0.48%$29.66 - $32.75
($31.36)
$ 28.28-10%Reduce -40.13%7,276,622
PFENWQ Managers 2014-03-31 Reduce-0.39%$29.66 - $32.75
($31.39)
$ 28.28-10%Reduce -13.6%9,231,207
PFEJean-Marie Eveillard 2014-03-31 Reduce-0.19%$29.66 - $32.75
($31.39)
$ 28.28-10%Reduce -22.77%7,866,473
PFERobert Bruce 2013-12-31 Add0.17%$28.24 - $32.2
($30.7)
$ 28.28-8%Add 4.63%452,000
PFEJean-Marie Eveillard 2013-12-31 Add0.16%$28.24 - $32.2
($30.7)
$ 28.28-8%Add 23.07%10,186,005
PFEJoel Greenblatt 2013-12-31 Add0.11%$28.24 - $32.2
($30.7)
$ 28.28-8%Add 241.71%222,280
PFERonald Muhlenkamp 2013-12-31 Add0.05%$28.24 - $32.2
($30.7)
$ 28.28-8%Add 29.15%45,129
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PFE Brian Rogers 2014-09-3012,737,1150.21.4+3.66%
PFE Ray Dalio 2014-06-30393,0080.010.09+250.56%
PFE Vanguard Health Care Fund 2014-06-3014,934,0220.241.2+105.23%
PFE Joel Greenblatt 2014-06-301,741,3140.030.65+71.59%
PFE David Dreman 2014-06-3013,61500.03+14.88%
PFE Charles Brandes 2014-06-306,075,4600.12.2+5.78%
PFE Ken Fisher 2014-06-3031,482,4890.52+4.1%
PFE James Barrow 2014-06-3060,500,0580.952.4+1.01%
PFE Irving Kahn 2014-06-302,124,4890.039+0.55%
PFE Brian Rogers 2014-06-3012,287,1150.191.3
PFE Robert Bruce 2014-06-30452,0000.013.1
PFE Prem Watsa 2014-06-30235,00000.48
PFE Ruane Cunniff 2014-06-3010,98700-0.32%
PFE Ronald Muhlenkamp 2014-06-3041,01900.21-0.36%
PFE Mario Gabelli 2014-06-301,104,0700.020.17-5.28%
PFE John Keeley 2014-06-3089,83900.05-6.31%
PFE Dodge & Cox 2014-06-3048,902,0970.771.4-23.73%
PFE NWQ Managers 2014-06-306,363,0060.11.9-31.07%
PFE HOTCHKIS & WILEY 2014-06-30128,80000.01-33.68%
PFE Michael Price 2014-06-30107,10000.39-69.14%
PFE Jean-Marie Eveillard 2014-06-302,303,7620.040.17-70.71%
PFE John Hussman 2014-06-30000Sold Out
PFE Mark Hillman 2013-12-3123,98201.1
Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OLSON LAURIE JExecutive Vice President 2014-06-12Sell36,275$29.53-4.23view
Germano Geno JGroup President 2014-06-02Sell30,000$29.68-4.72view
YOUNG JOHN DGroup President 2014-03-17Sell9,000$31.38-9.88view
PFIZER INC10% Owner 2014-03-12Buy272,727$11157.09view
CANGIALOSI LORETTA VSr. Vice President, Controller 2014-03-04Sell102,943$32.05-11.76view
Dolsten MikaelPresident R&D 2014-03-04Sell35,789$32.58-13.2view
SUSMAN SALLYExecutive Vice President 2014-03-04Sell67,585$32.59-13.22view
PFIZER INC10% Owner 2014-02-04Buy227,261$8253.5view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell131,810$30.82-8.24view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell28,190$30.86-8.36view

Press Releases about PFE :

    Quarterly/Annual Reports about PFE:

      News about PFE:

      Articles On GuruFocus.com
      Guru Stocks at 52-Week Lows: GOOG, PFE, UN, E, MTU Oct 20 2014 
      10 Stocks With The Highest Share Buyback Volume In 2014 Oct 03 2014 
      A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
      The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead Sep 16 2014 
      The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead Sep 16 2014 
      I Am Sure This Pharma-Company Suits Your Portfolio Aug 28 2014 
      Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures Aug 28 2014 
      Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG Aug 18 2014 
      A Strong Candidate for Investor´s Portfolios Aug 12 2014 
      Legendary Investor Irving Kahn's Top Five Stocks Aug 08 2014 

      More From Our Partners
      UPDATE: FDA Has Approved New Labeling on Pfizer's Embeda Oct 17 2014 - BENZINGA

      More From Other Websites
      Can Valeant's Strong Q3 Entice Allergan? Oct 20 2014
      Why Pfizer (PFE) Stock Remains a 'Buy' at TheStreet Oct 20 2014
      3 Stocks Reiterated As A Buy: PFE, MU, CELG Oct 20 2014
      ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S. Oct 20 2014
      Anti-abuse label approved for painkiller Embeda Oct 17 2014
      Pfizer's AstraZeneca pursuit knocked by Shire deal collapse Oct 17 2014
      FDA Approves Abuse Deterrent Labeling for EMBEDA® (morphine sulfate and naltrexone hydrochloride)... Oct 17 2014
      Pfizer Loses a Bet on Removing Serious Warnings From its Chantix Pill Oct 17 2014
      [$$] Panel Votes to Keep Strong Warning on Smoking-Cessation Drug Oct 17 2014
      FDA votes to keep black box warning on Pfizer anti-smoking drug Oct 16 2014
      FDA votes to keep black box warning on Pfizer anti-smoking drug Oct 16 2014
      FDA panel votes to keep severe warning on Pfizer anti-smoking drug Oct 16 2014
      FDA votes to keep black box warning on Pfizer anti-smoking drug Oct 16 2014
      The Best-Selling Biologic Drugs Oct 16 2014
      Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals Oct 16 2014
      [video] S&P 500: When Will the Selling Stop? Oct 16 2014
      BUZZ-Healthcare sector: Investors shooting from the hip Oct 16 2014
      AbbVie recommends stockholders to reject Shire deal Oct 15 2014
      AbbVie recommends stockholders to reject Shire deal Oct 15 2014
      Shire Falls, AbbVie Questioned On Buyout Backtrack Oct 15 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      SEENSCO
      ReplySEENSCO - 4 months ago
      PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK